Rethinking the Routine: Is it Time to Change How Often We Screen for STIs?
For years, the gold standard for gay, bisexual, and trans men who have sex with men (GBMSM) has been a rigorous three-month screening cycle for chlamydia and gonorrhoea. It was a rhythm of responsibility—a way to ensure personal health and protect partners. However, a growing debate among top clinicians and health agencies suggests that our approach to “routine” testing may be overdue for an update.
The core of the discussion isn’t about whether we should test, but how often. As medical understanding of asymptomatic infections evolves, the medical community is weighing the benefits of frequent screening against the risks of antibiotic overuse and systemic inefficiency.
The Case for Less Frequent Screening: Why ‘Less’ Might Be ‘More’
At first glance, testing less often seems counterintuitive. But from a clinical perspective, there are compelling reasons to move toward a six-month window.
Combating Antibiotic Resistance
One of the most pressing global health threats is the rise of “superbugs.” Gonorrhoea, in particular, is notorious for its ability to evolve. Since the 1940s, it has become resistant to five different classes of antibiotics. We are now relying on ceftriaxone, and while resistance is still rare, It’s increasing.
By screening and treating every single asymptomatic case every three months, we may be inadvertently accelerating this resistance. Reducing the frequency of antibiotic prescriptions helps preserve the efficacy of the drugs we have left.
The Phenomenon of Spontaneous Clearance
Emerging data suggests that the body is more capable of fighting off certain STIs than previously thought. Some studies indicate that 24% of chlamydia infections clear spontaneously within 27 days, and up to 80% may clear within a year without intervention. When we treat an infection that was already on its way out, we may be providing unnecessary medication.
Protecting the Microbiome
Antibiotics aren’t scalpels; they are sledgehammers. They don’t just kill the “bad” bacteria; they disrupt the natural biome of the gut and other areas of the body. Reducing unnecessary antibiotic cycles helps maintain a healthier internal ecosystem.
The Risks of Scaling Back: Transmission and Trust
Despite the clinical advantages of less frequent testing, many doctors and patients are hesitant. The primary fear? The “transmission gap.”
If a person acquires an infection one month after a test, a six-month cycle means they could potentially be infectious for five months before their next screen. While many infections are mild, untreated chlamydia and gonorrhoea can lead to severe complications, such as Pelvic Inflammatory Disease (PID) in women and trans people, or disseminated infections that spread through the bloodstream to the joints and skin.
The Loss of the ‘Clinical Touchpoint’
Beyond the lab results, the three-month appointment serves as a vital mental health and risk-management check-in. These visits allow clinicians to discuss safeguarding, drug use, and emotional well-being. Halving these appointments could mean missing critical opportunities for early intervention in a patient’s overall health.
The Cultural Weight of Testing
For many in the LGBT+ community, regular testing is more than a medical necessity—it is a badge of social responsibility. In an era where stigma still exists, the act of “staying clear” is a way of validating one’s commitment to the community. A move toward less frequent testing could be perceived as a reduction in care or a shift toward cost-cutting rather than patient health.
The Future: A Personalized Approach to Sexual Health
The trend is moving away from “one size fits all” and toward stratified care. Future guidelines may likely implement a tiered system:

- High-Frequency Screening (3 Months): Reserved for those with higher vulnerability, people selling sex, or those not using PrEP.
- Standard Screening (6 Months): For low-risk individuals with stable partners or those utilizing comprehensive prevention strategies.
- Hybrid Models: Using at-home postal kits for HIV and syphilis every three months, while keeping in-clinic visits for more comprehensive checks every six.
For more information on the latest clinical guidelines, you can visit the British Association for Sexual Health and HIV (BASHH) or check out our guide on understanding asymptomatic infections.
Frequently Asked Questions
Q: Does “asymptomatic” mean the infection isn’t dangerous?
A: Not necessarily. While many asymptomatic infections are mild, they can still be transmitted to others and, if left untreated for long periods, can lead to complications like infertility or systemic infection.
Q: Why is antibiotic resistance a problem for STIs?
A: If bacteria evolve to resist all available antibiotics, we could face a future where common STIs become untreatable, leading to permanent health damage for patients.
Q: Should I stop testing every three months right now?
A: No. You should follow the current guidelines provided by your healthcare provider until official clinical recommendations change.
Join the Conversation
Do you value the peace of mind that comes with three-monthly testing, or do you think it’s time to reduce the frequency to fight antibiotic resistance?
Let us know in the comments below or subscribe to our newsletter for the latest updates in sexual wellness and healthcare trends.
